ATE496134T1 - Multigene vectoren und methoden für eine erhöhte expression von rekombinanten polypeptiden - Google Patents

Multigene vectoren und methoden für eine erhöhte expression von rekombinanten polypeptiden

Info

Publication number
ATE496134T1
ATE496134T1 AT03808015T AT03808015T ATE496134T1 AT E496134 T1 ATE496134 T1 AT E496134T1 AT 03808015 T AT03808015 T AT 03808015T AT 03808015 T AT03808015 T AT 03808015T AT E496134 T1 ATE496134 T1 AT E496134T1
Authority
AT
Austria
Prior art keywords
methods
expression
increased expression
recombinant polypeptides
materials
Prior art date
Application number
AT03808015T
Other languages
English (en)
Inventor
Arnold Horwitz
Original Assignee
Xoma Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xoma Technology Ltd filed Critical Xoma Technology Ltd
Application granted granted Critical
Publication of ATE496134T1 publication Critical patent/ATE496134T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/65—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression using markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/66—General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/10—Plasmid DNA
    • C12N2800/106—Plasmid DNA for vertebrates
    • C12N2800/107—Plasmid DNA for vertebrates for mammalian
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT03808015T 2002-03-29 2003-03-31 Multigene vectoren und methoden für eine erhöhte expression von rekombinanten polypeptiden ATE496134T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36853002P 2002-03-29 2002-03-29
PCT/US2003/010154 WO2004033693A1 (en) 2002-03-29 2003-03-31 Methods vectors plasmids and methods for increasing expression of recombinant polypeptides

Publications (1)

Publication Number Publication Date
ATE496134T1 true ATE496134T1 (de) 2011-02-15

Family

ID=32093683

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03808015T ATE496134T1 (de) 2002-03-29 2003-03-31 Multigene vectoren und methoden für eine erhöhte expression von rekombinanten polypeptiden

Country Status (9)

Country Link
US (4) US7192737B2 (de)
EP (2) EP2311962B1 (de)
JP (2) JP4554370B2 (de)
AT (1) ATE496134T1 (de)
AU (2) AU2003300588B2 (de)
CA (1) CA2492008C (de)
DE (1) DE60335794D1 (de)
DK (1) DK1492874T3 (de)
WO (1) WO2004033693A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100311954A1 (en) * 2002-03-01 2010-12-09 Xencor, Inc. Optimized Proteins that Target Ep-CAM
JP4554370B2 (ja) * 2002-03-29 2010-09-29 ゾーマ テクノロジー リミテッド 多重遺伝子プラスミドおよび組み換えポリペプチドの発現増加法
US20050009097A1 (en) * 2003-03-31 2005-01-13 Better Marc D. Human engineered antibodies to Ep-CAM
ATE534900T1 (de) * 2003-07-09 2011-12-15 Life Technologies Corp Verfahren zum testen einer protein-protein- wechselwirkung
US20070224615A1 (en) * 2003-07-09 2007-09-27 Invitrogen Corporation Methods for assaying protein-protein interactions
US20050202539A1 (en) * 2004-03-11 2005-09-15 Hydra Biosciences System for screening eukaryotic membrane proteins
EP1833976A2 (de) * 2004-12-03 2007-09-19 Xoma Technology Ltd. Verfahren und materialien zur expression eines rekombinanten proteins
EP1833979A4 (de) * 2004-12-14 2009-03-25 Millennium Pharm Inc Nukleinsäuremoleküle zur optimierten cab-2-expression und deren verwendung
US20070072174A1 (en) * 2005-09-28 2007-03-29 Sayler Gary S Bioreporter for detection of microbes
EP1783228A1 (de) * 2005-11-08 2007-05-09 ETH Zürich Rekombinante Expression von Multiproteinkomplexen mit Hilfe von Multigenen
JP2009529915A (ja) 2006-03-20 2009-08-27 ゾーマ テクノロジー リミテッド ガストリン物質に対して特異的なヒト抗体および方法
AR064801A1 (es) 2006-08-18 2009-04-29 Xoma Technology Ltd Anticuerpo especifico prlr (receptor de prolactina) y sus usos
WO2008070780A1 (en) 2006-12-07 2008-06-12 Novartis Ag Antagonist antibodies against ephb3
NZ580378A (en) * 2007-03-30 2012-11-30 Abbott Lab Recombinant expression vector elements (reves) for enhancing expression of recombinant proteins in host cells
US8071332B2 (en) 2007-08-10 2011-12-06 Toto Ltd. Recombinant mammal cells, method of producing thereof, and method of producing proteins of interest
JP2011500086A (ja) * 2007-10-22 2011-01-06 シェーリング コーポレイション 完全ヒト抗ｖｅｇｆ抗体および使用方法
US8318162B2 (en) * 2009-07-16 2012-11-27 Xoma Technology Ltd. Antibodies to high molecular weight melanoma associated antigen
ES2432242T3 (es) * 2009-07-29 2013-12-02 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Sistema mejorado de expresión de pentraxina 3 larga humana y sus usos
WO2012011955A2 (en) * 2010-07-21 2012-01-26 Duke University Compositions and methods for production and screening of monoclonal antibodies
WO2012077128A1 (en) * 2010-12-07 2012-06-14 Intas Biopharmaceuticals Limited A novel cell line development process to produce recombinant proteins using twin vector expression system
DK2971005T3 (da) * 2013-03-12 2020-08-24 Agc Biologics Inc Forbedret rekombinant proteinekspression ved anvendelse af en hybrid CHEF1-promotor
US9388239B2 (en) 2014-05-01 2016-07-12 Consejo Nacional De Investigation Cientifica Anti-human VEGF antibodies with unusually strong binding affinity to human VEGF-A and cross reactivity to human VEGF-B
AR102333A1 (es) 2014-08-19 2017-02-22 Regeneron Pharma Selectividad eficiente de proteínas recombinadas
WO2018047154A1 (en) 2016-09-07 2018-03-15 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Anti-nkp46 antibodies and therapeutic use of same
US10318741B2 (en) 2016-11-21 2019-06-11 Bank Of America Corporation Data security and risk ranking tool
IL253984A0 (en) 2017-08-14 2017-09-28 Yeda Res & Dev Immunotherapy against aranviruses that bind through transferrin receptor 1 (tfr1
WO2019038338A1 (en) * 2017-08-23 2019-02-28 Sandoz Ag PROTEIN EXPRESSION SYSTEM WITH MULTIPLE GENIC COPIES
SG11202003237QA (en) * 2017-11-02 2020-05-28 Systimmune Inc Bispecific antibodies and methods of making and using thereof
IL276627A (en) 2020-08-10 2022-03-01 Yeda Res & Dev Compositions for diagnosis and treatment of coronavirus infections
CN117701410A (zh) * 2023-12-18 2024-03-15 中国海洋大学 介导协氧蛋白和褐藻胶裂解酶的双转录单元重组菌和应用

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4612282A (en) 1981-12-15 1986-09-16 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Monoclonal antibodies reactive with human breast cancer
US4880741A (en) 1983-10-06 1989-11-14 Pfizer Inc. Process for transformation of Yarrowia lipolytica
IN163393B (de) * 1983-10-06 1988-09-17 Pfizer
US5198541A (en) 1987-08-11 1993-03-30 New York University Dna encoding bactericidal/permeability-increasing proteins
US5576184A (en) 1988-09-06 1996-11-19 Xoma Corporation Production of chimeric mouse-human antibodies with specificity to human tumor antigens
GB9115364D0 (en) 1991-07-16 1991-08-28 Wellcome Found Antibody
EP0571613B1 (de) 1991-12-13 2003-09-17 Xoma Corporation Verfahren und materialien zur herstellung von modifizierten variablen antikörperdomänen und ihre therapeutische verwendung
AU669723B2 (en) 1992-05-19 1996-06-20 Xoma Corporation Improved methods for the preparation of endotoxin-binding proteins
US5643570A (en) 1992-05-19 1997-07-01 Xoma Corporation BPI-immunoglobulin fusion proteins
US5420019A (en) 1993-02-02 1995-05-30 Xoma Corporation Stable bactericidal/permeability-increasing protein muteins
US5652332A (en) 1993-03-12 1997-07-29 Xoma Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
US5733872A (en) 1993-03-12 1998-03-31 Xoma Corporation Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
JPH08509703A (ja) 1993-03-12 1996-10-15 ゾーマ コーポレイション 殺菌／透過性増加タンパク質産物の治療用途
US5348942A (en) 1993-03-12 1994-09-20 Xoma Corporation Therapeutic uses of bactericidal/permeability increasing protein products
ES2123134T3 (es) 1993-03-12 1999-01-01 Xoma Corp Peptidos biologicamente activos de dominios funcionales de la proteina bactericida aumentadora de la permeabilidad y usos de los mismos.
US5447913A (en) 1994-03-11 1995-09-05 Xoma Corporation Therapeutic uses of bactericidal/permeability-increasing protein dimer products
ATE256147T1 (de) 1994-09-15 2003-12-15 Xoma Technology Ltd Peptide gegen pilzen
US5866402A (en) 1995-05-05 1999-02-02 Chiron Corporation Chimeric MCP and DAF proteins with cell surface localizing domain
WO1997004008A1 (en) 1995-07-20 1997-02-06 Xoma Corporation Anti-fungal peptides
US5851802A (en) 1996-03-22 1998-12-22 Xoma Corporation Methods for recombinant microbial production of fusion proteins and BPI-derived peptides
US5998174A (en) * 1997-05-12 1999-12-07 University Of Pittsburgh Of The Commonwealth System Of Higher Education Multigene vectors
US6013631A (en) 1998-06-19 2000-01-11 Xoma Corporation Bactericidal/permeability-increasing protein (BPI) deletion analogs
US6316253B1 (en) 1999-11-01 2001-11-13 Chiron Corporation Expression vectors, transfection systems, and method of use thereof
US6908751B2 (en) * 2000-04-26 2005-06-21 Zymogenetics, Inc. Methods for enhancing the expression of a protein of interest by recombinant host cells
JP4554370B2 (ja) 2002-03-29 2010-09-29 ゾーマ テクノロジー リミテッド 多重遺伝子プラスミドおよび組み換えポリペプチドの発現増加法
US9320293B2 (en) 2008-06-06 2016-04-26 Gold Medal Products Company Popcorn kettle
US9402401B1 (en) 2008-11-03 2016-08-02 William P. Benzel Extruded three loop pretzel having a twist-knot appearance at its middle portion, apparatus and die for making said pretzel, and method of forming said pretzel
CA2816272C (en) 2009-10-28 2017-06-27 Advanced Businesslink Corporation Role-based modernization of legacy applications
WO2012090935A1 (ja) 2010-12-28 2012-07-05 日立金属株式会社 フェライト焼結磁石及びその製造方法
US9603845B2 (en) 2012-05-15 2017-03-28 Taiho Pharmaceutical Co., Ltd. Prophylactic agent and/or therapeutic agent for stress urinary incontinence
US9410427B2 (en) 2012-06-05 2016-08-09 United Technologies Corporation Compressor power and torque transmitting hub
CN104797263B (zh) 2012-10-22 2018-02-09 Zs制药公司 用于治疗高钾血症的微孔硅酸锆
JP6453542B2 (ja) 2013-02-14 2019-01-16 ソウル セミコンダクター カンパニー リミテッド 半導体装置及びこれの製造方法
KR20150087669A (ko) 2014-01-22 2015-07-30 삼성전기주식회사 컨커런트 다중밴드 고주파 증폭회로
US9503125B2 (en) 2014-05-08 2016-11-22 Sandisk Technologies Llc Modified trellis-based min-max decoder for non-binary low-density parity-check error-correcting codes
US9402465B1 (en) 2014-06-11 2016-08-02 Paul Edward LaForge Shaving brush with vented holder
US9218176B1 (en) 2014-06-13 2015-12-22 International Business Machines Corporation Software deployment in a distributed virtual machine environment

Also Published As

Publication number Publication date
EP2311962A1 (de) 2011-04-20
EP2311962B1 (de) 2013-03-13
AU2009200829A1 (en) 2009-03-19
AU2003300588B2 (en) 2008-12-04
CA2492008C (en) 2012-06-26
US7192737B2 (en) 2007-03-20
US20080145895A1 (en) 2008-06-19
AU2003300588A1 (en) 2004-05-04
JP2006141415A (ja) 2006-06-08
US20120178126A1 (en) 2012-07-12
JP4554370B2 (ja) 2010-09-29
US7993915B2 (en) 2011-08-09
US20070281334A1 (en) 2007-12-06
JP2005528925A (ja) 2005-09-29
EP1492874A1 (de) 2005-01-05
US20030203447A1 (en) 2003-10-30
CA2492008A1 (en) 2004-04-22
DE60335794D1 (de) 2011-03-03
DK1492874T3 (da) 2011-03-14
US8497096B2 (en) 2013-07-30
EP1492874B1 (de) 2011-01-19
WO2004033693A1 (en) 2004-04-22

Similar Documents

Publication Publication Date Title
DE60335794D1 (de) Multigene vectoren und methoden für eine erhöhte expression von rekombinanten polypeptiden
DE60227064D1 (de) Von rna polymerasen abstammende polypeptide und ihre verwendungen
ATE454393T1 (de) Egvii-endoglucanase und dafür codierende nukleinsäuren
TR199901109T2 (xx) Geni� spektrumlu delta-endotoksinler.
DE69838334D1 (de) Kdr, ein menschlicher tyrosin kinase rezeptor
ATE301716T1 (de) Vmp-ähnliche sequenzen von pathogener borrelia
ATE504645T1 (de) Für fructooligosaccharid-nutzende verbindungen codierende nukleinsäuren aus lactobacillus acidophilus und verwendungen davon
EP1482047A4 (de) PROTEIN ODER POLYPEPTID MIT LACHRYMATORSYNTHASEAKTIVITÄT, DAS PROTEIN ODER POLYPEPTID CODIERENDE DNA, VERFAHREN ZUR HERSTELLUNG VON PROTEIN ODER POLYPEPTID MIT LACHRYMATORSYNTHASEAKTIVITÄT UNTER VERWENDUNG DER DNA SOWIE DIE TRANSLATION DER DAS PROTEIN ODER PEPTID BETREFFENDEN mRNA HEMMENDES NUKLEINSÄUREMOLEKÜL
BR9902019A (pt) Moléculas de polinucleotìdios que codificam proteìnas de neospora.
BRPI0516504A (pt) polipeptìdeo tendo atividade de fitase e seqüência de nucleotìdeo codificando o mesmo
ATE488592T1 (de) Auf antibiotikum basierendes genregulationssystem
ATE556140T1 (de) Aav vektoren für die gentherapie von rheumatischer arthritis
DE602004021922D1 (de) Induktion der blütenbildung
WO2003074675A3 (en) Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof
WO2002072765A3 (en) Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof
ATE423200T1 (de) Neues plexin-polypeptid, dieses codierende dna und verwendung davon
DK1716237T3 (da) Orotat-transportørkodende markørgener
WO2002077190A8 (en) Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof
ATE546534T1 (de) Expression system für rekombinante proteine
WO2003070882A3 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and used thereof
CO5400145A1 (es) Proteina asociada con enfermedad
WO2002079494A3 (en) Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof
WO2002061088A3 (en) Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof
WO2002074976A3 (en) Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof
ECSP993160A (es) Acidos nucleicos y polipeptidos homologos il-17, vectores,celulas huesped, metodos y usos de los mismos

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties